Clinical Trials Logo

Preterm Delivery clinical trials

View clinical trials related to Preterm Delivery.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05278130 Recruiting - Bacterial Vaginosis Clinical Trials

Serial Screening and Treatment of Bacterial Vaginosis Trial

SECRETIVA
Start date: October 20, 2022
Phase: N/A
Study type: Interventional

The purpose of this investigator-initiated randomized control trial is to determine if bacterial vaginosis infection increases the likelihood of preterm delivery in women with history of preterm delivery. Subjects will be randomized in a two-arm study to undergo predetermined intervals of testing for bacterial vaginosis or control.

NCT ID: NCT04374916 Recruiting - Preterm Delivery Clinical Trials

Evaluation of a New Predictive Test of Preterm Birth in Case of Threatened Preterm Labor

PREMAQUICK
Start date: August 11, 2020
Phase: N/A
Study type: Interventional

Threatened preterm labor (TPL) is defined by cervical changes and regular and painful uterine contractions occurring between 24 and 36 + 6 weeks of gestation that may or may not lead to premature labor and delivery. There is no reliable way to predict preterm delivery. The study's hypothesis is that the Premaquick® test can improve the prediction of preterm delivery. The investigators also want to compare this test with the Partosure® (Placental alpha microglobulin-1) test.

NCT ID: NCT03608995 Recruiting - Preterm Labor Clinical Trials

Diagnostic Tests in the Context of Threatened Preterm Labour

PREMAQUICK
Start date: August 21, 2018
Phase: N/A
Study type: Interventional

The primary purpose of the protocol is to compare the diagnostic accuracy in terms of positive and negative predictive values of Premaquick © (combined detection of IL-6 / IGFBP-1 total / IGFBP-1 native) and Quikcheck fFN ™ (fibronectin detection) tests for prediction of spontaneous delivery within 7 days in women with threatened preterm labor. The study hypothesis is that combined detection of IL-6 / IGFBP-1 total / IGFBP-1 native dice the admission will improve the prediction of delivery compared to the detection of fetal fibronectin alone in women with threatened preterm labor.

NCT ID: NCT03123926 Recruiting - Preterm Delivery Clinical Trials

Spontaneous Preterm Birth Marker Test

Start date: November 2016
Phase: N/A
Study type: Observational

The prediction of preterm birth is beneficial because it initiates early treatment to minimize risk. It defines a population at risk to provide particular treatment and may lead us to a better understanding the mechanisms of preterm birth. The understanding of the mechanisms and etiology consequently leads to the possibility of early intervention and effective management aiming at preventing preterm birth. Five most common interventions for preventing and treating preterm birth are antibiotics, cervical cerclage, bed rest, progesterone, and tocolytic therapy. However, there are insufficient evidence showing the efficacy of cerclage and bed rest; antibiotics may only delay but not prevent the preterm birth; the use of certain tocolytics needs to be considered against the possible adverse effects. The early detection of pregnant women with high risk for preterm delivery would be the ideal solution to prevent preterm birth. However, to date, there is inadequate literature and little knowledge of diagnosis, treatment, prevention and prediction of preterm birth.

NCT ID: NCT02420743 Recruiting - Preterm Delivery Clinical Trials

Serum Ferritin Concentration and Fetal MCA Doppler as Predictors for Preterm Delivery

SFMCA
Start date: October 2014
Phase:
Study type: Observational

Pregnant women with iron deficiency anemia during third trimester will be assessed for serum ferritin and peak systolic value for fetal middle cerebral artery to find out their correlation with preterm delivery.

NCT ID: NCT01232192 Recruiting - Pregnant Women Clinical Trials

Study of Antenatal Model to Prevent Preterm Delivery

AACP
Start date: January 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether antenatal model in vaginosis are effective in preventing vaginal infection and preterm delivery